Shopping Cart
Remove All
Your shopping cart is currently empty
Vaccinia virus capping enzyme is a transcription initiation factor that functions as a heterodimer composed of D1 (844 aa) and D12 (287 aa) polypeptides, capable of performing all three steps of m7GpppRNA synthesis. It has been widely utilized as a reagent for in vitro capping and for labeling capped RNA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Vaccinia virus capping enzyme is a transcription initiation factor that functions as a heterodimer composed of D1 (844 aa) and D12 (287 aa) polypeptides, capable of performing all three steps of m7GpppRNA synthesis. It has been widely utilized as a reagent for in vitro capping and for labeling capped RNA. |
| In vitro | Vaccinia virus capping enzyme is involved in the formation of the 5' cap structure and the termination of early transcription. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.